Literature DB >> 28499941

MTUS1, a gene encoding angiotensin-II type 2 (AT2) receptor-interacting proteins, in health and disease, with special emphasis on its role in carcinogenesis.

Ibrahim Bozgeyik1, Onder Yumrutas2, Esra Bozgeyik3.   

Abstract

Loss of tumor suppressor activity is a frequent event in the formation and progression of tumors and has been listed as an important hallmark of cancers. Microtubule-Associated Scaffold Protein 1 (MTUS1) is a candidate tumor suppressor gene which is reported to be frequently down-regulated in a variety of human cancers including pancreas, colon, bladder, head-and-neck, ovarian, breast cancers, gastric, lung cancers. It is also reported to be implicated in several types of pathologies such as cardiac hypertrophy, atherosclerosis, and SLE-like lymphoproliferative diseases. Moreover, MTUS1-encoded proteins are shown to be involved in the regulation of vital cellular processes such as proliferation, differentiation, DNA repair, inflammation, vascular remodeling and senescence. However, the current knowledge is very limited about the role of this gene in human cancers as well as other type diseases. Besides, there is no literature report which summarizes and criticizes the importance of MTUS1 in the cellular processes, especially in the processes of carcinogenesis. Accordingly, in this comprehensive review, we tried to shed light on the role of tumor suppressor MTUS1/ATIP in health and disease, putting special emphasis on its role in the development and progression of human cancers as well as associated molecular mechanisms and the reasons behind MTUS1/ATIP deficiency, which have been not well documented previously.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  ATIP; Angiotensin-II type 2 receptor-interacting protein; Cancer; MTSG1; MTUS1; Microtubule-Associated Scaffold Protein 1; Mitochondrial Tumor Suppressor 1; Tumor Suppressor Gene

Mesh:

Substances:

Year:  2017        PMID: 28499941     DOI: 10.1016/j.gene.2017.05.019

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

Review 1.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

2.  The Actin Bundling Protein Fascin-1 as an ACE2-Accessory Protein.

Authors:  Blessing Ogunlade; Jessie J Guidry; Snigdha Mukerjee; Srinivas Sriramula; Eric Lazartigues; Catalin M Filipeanu
Journal:  Cell Mol Neurobiol       Date:  2020-08-31       Impact factor: 5.046

3.  Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma.

Authors:  Jongmin Sim; Yeseul Kim; Hyungsung Kim; Seongsik Bang; Seungyun Jee; Seongun Park; Su-Jin Shin; Kiseok Jang
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

Review 4.  The mitochondrial landscape of ovarian cancer: emerging insights.

Authors:  Pallavi Shukla; Keshav K Singh
Journal:  Carcinogenesis       Date:  2021-05-28       Impact factor: 4.944

5.  A genomic mutation spectrum of collecting duct carcinoma in the Chinese population.

Authors:  Huaru Zhang; Xiaojun Lu; Gang Huang; Meimian Hua; Wenhui Zhang; Tao Wang; Liqun Huang; Ziwei Wang; Qing Chen; Jing Li; Qing Yang; Guosheng Yang
Journal:  BMC Med Genomics       Date:  2022-01-03       Impact factor: 3.063

Review 6.  The Effect of Local Renin Angiotensin System in the Common Types of Cancer.

Authors:  Moudhi Almutlaq; Abir Abdullah Alamro; Hassan S Alamri; Amani Ahmed Alghamdi; Tlili Barhoumi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-03       Impact factor: 5.555

7.  MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.

Authors:  Lin-Yao Cheng; Mao-Sen Huang; Hua-Ge Zhong; Hai-Ming Ru; Si-Si Mo; Chun-Yin Wei; Zi-Jie Su; Xian-Wei Mo; Lin-Hai Yan; Wei-Zhong Tang
Journal:  World J Surg Oncol       Date:  2022-08-13       Impact factor: 3.253

Review 8.  Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer.

Authors:  Maria M Haykal; Sylvie Rodrigues-Ferreira; Clara Nahmias
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

9.  Mitochondrial tumor suppressor 1 is a target of AT-rich interactive domain 1A and progesterone receptor in the murine uterus.

Authors:  Hye Jin Chang; Hanna E Teasley; Jung-Yoon Yoo; Tae Hoon Kim; Jae-Wook Jeong
Journal:  Asian-Australas J Anim Sci       Date:  2018-04-12       Impact factor: 2.509

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.